new semaglutide drugs Demand Rising for 'Bootlegged' Weight-Loss Drug GLP-1 drugs like Ozempic deliver
Description
Pre-gestational diabetes affects approximately 12% of pregnancies, while GDM prevalence ranges from 3.821%
Reply to comment on the effect of semaglutide and GLP-1 RAs on risk of nonarteritic anterior ischemic optic neuropathy [published online ahead of print June 20, 2025]
Douros, M.B
conducted a retrospective study comparing the recurrence rates of acute pancreatitis among patients with T2DM or obesity taking GLP1 RAs versus those who did not [25]
Patients using GLP-1 therapy often experience significant reductions in hemoglobin A1c levels and improved beta-cell function crucial for insulin production and overall pancreatic health
